Pharma Journalist - Page 72 of 936 -

Zymeworks to Acquire Theravance Biopharma in $929 Million Deal

EMA Panel Backs Lilly’s Jaypirca for Chronic Lymphocytic Leukemia

Talawar Therapeutics Announces $285 Million Nasdaq Merger Deal

Acumen and JCR Partner to Develop Enhanced Brain Delivery Alzheimer’s Therapy

Navamedic Finalizes Acquisition of DNE Pharma Business

Secarna Pharmaceuticals and Vect-Horus Partner to Boost RNA Therapeutics Delivery for CNS Disorders

Transcend Therapeutics Gets Breakthrough Therapy Designation for TSND-201 in PTSD

FDA Approves Merck Animal Health’s BRAVECTO QUANTUM Injectable for Flea and Tick Protection

Merck to Acquire Verona Pharma, Adding First-in-Class COPD Drug Ohtuvayre to Pipeline

Lupin and Zentiva Ink Licensing Deal to Commercialize Certolizumab in Europe

AbbVie and IGI Ink Global Deal for First-in-Class Trispecific Antibody ISB 2001

Biocytogen Signs Antibody Licensing Deal with BeOne Medicines to Boost Drug Development

FDA Grants Orphan Drug Status to Adcentrx’s ADRX-0405 for Gastric Cancer